Deutsche Borse AG:企業のM&A・事業提携・投資動向

◆英語タイトル:Deutsche Borse AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1398
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Deutsche Borse AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Deutsche Borse AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Deutsche Borse AG since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Deutsche Borse AG’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Deutsche Borse AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Deutsche Borse AG’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Deutsche Borse AG and its subsidiaries since 2007.
- Information about key financial and legal advisors for Deutsche Borse AG’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Deutsche Borse AG’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 24
Corporate Venturing – Overview 24
Corporate Venturing – Deal reports 25
PARTNERSHIP 39
Partnership – Overview 39
Partnership – Deal reports 40
DIVESTMENTS 46
Divestments – Overview 46
Divestments – Deal reports 47
APPENDIX 68
Contact Us 68
About MarketLine Financial Deals Database 68
Deal Definition and Methodology 70
About MarketLine 77

List of Tables
Table 1: Deutsche Borse AG M&A volume and value trend (2014-YTD2018)
Table 2: Deutsche Borse AG M&A activity by geography (2014-YTD2018)
Table 3: Deutsche Borse AG corporate venturing volume and value trend (2014-YTD2018)
Table 4: Deutsche Borse AG corporate venturing by geography (2014-YTD2018)
Table 5: Deutsche Borse AG partnership volume and value trend (2014-YTD2018)
Table 6: Deutsche Borse AG partnership trend by key deal type (2014-YTD2018)
Table 7: Deutsche Borse AG divestments volume and value trend (2014-YTD2018)
Table 8: Deutsche Borse AG divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Deutsche Borse AG M&A volume and value trend (2014-YTD2018)
Figure 2: Deutsche Borse AG M&A activity by geography (2014-YTD2018)
Figure 3: Deutsche Borse AG corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Deutsche Borse AG corporate venturing by geography (2014-YTD2018)
Figure 5: Deutsche Borse AG partnership volume and value trend (2014-YTD2018)
Figure 6: Deutsche Borse AG partnership trend by key deal type (2014-YTD2018)
Figure 7: Deutsche Borse AG divestments volume and value trend (2014-YTD2018)
Figure 8: Deutsche Borse AG divestments by geography (2014-YTD2018)

★海外企業調査レポート[Deutsche Borse AG:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ricoh Company, Ltd. (7752):企業の財務・戦略的SWOT分析
    Ricoh Company, Ltd. (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Amarin Corp Plc (AMRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of trigl …
  • WPPI Energy, Inc.:企業の戦略的SWOT分析
    WPPI Energy, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kleo Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kleo Pharmaceuticals Inc (Kleo Pharmaceuticals) is a biotechnology company that develops small molecules in the field of immunotherapy to emulate biologics. The company provides adaptable technology platforms such as antibody recruiting molecules (ARMs) and synthetic antibody mimics (SyAMs) …
  • W. R. Grace & Co:企業の戦略・SWOT・財務分析
    W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report Summary W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Strategic Resources Inc (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cardiatis SA:製品パイプライン分析
    Summary Cardiatis SA (Cardiatis) is a medical device company that develops a multilayer technology platform for endovascular aneurysm. The company offers a three dimensional multilayer braided stent system for endovascular aneurysm repair. Its multilayer flow modulator include aortic, peripheral, bi …
  • LinkedIn Corp:企業の戦略的SWOT分析
    LinkedIn Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Idaho Power Co:電力:M&Aディール及び事業提携情報
    Summary Idaho Power Company (Idaho Power), a subsidiary of IDACORP, Inc., is an electric utility that carries out the generation, purchase, transmission, distribution and sale of electric energy. Idaho Power is regulated by the Federal Energy Regulatory Commission (FERC), as well as state regulatory …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pier 1 Imports, Inc.:戦略・SWOT・企業財務分析
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ricerca Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Olon SpA, is a contract research organization that offers accelerate drug development services. The organization's services comprise drug safety and metabolism, chemical development, agrochemicals and other commercial s …
  • Sunshine Biopharma Inc (SBFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …
  • SEEK Limited:企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Biotec Pharmacon ASA (BIOTEC):企業の財務・戦略的SWOT分析
    Summary Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Cosmos Insurance Public Company Ltd
    Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmos Insurance Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆